Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.50p
   
  • Change Today:
      1.50p
  • 52 Week High: 13.30
  • 52 Week Low: 5.63
  • Currency: UK Pounds
  • Shares Issued: 443.23m
  • Volume: 741,987
  • Market Cap: £46.54m
  • Beta: 0.06

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1230.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 52.2 n/a
Pr/Book 30.1  
Latest F'cast
Revenue 88.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OBI Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.79 (16.27) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 2.57 (50.08) (63.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.64 (19.37) (10.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1.20 (14.41) (7.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OBI Company Announcements

Ondine Presents Groundbreaking Findings 10-Jun-2025 07:29 RNS
Exercise of Options 10-Jun-2025 07:00 RNS
UCL Shows Steriwave Effective Against Mucor Fungus 09-Jun-2025 07:00 RNS

OBI ShareCast News

Ondine Biomedical upbeat on new Steriwave test d... 09-Jun-2025 ShareCast
Ondine's Steriwave adopted by Ottawa Heart Insti... 05-Jun-2025 ShareCast
Ondine appoints Alan Thomas as interim finance c... 09-May-2025 ShareCast

Latest OBI Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

OBI Market Data

Currency UK Pounds
Share Price 10.50p
Change Today 1.50p
% Change 16.67 %
52 Week High 13.30
52 Week Low 5.63
Volume 741,987
Shares Issued 443.23m
Market Cap £46.54m
Beta 0.06

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.53% below the market average69.53% below the market average69.53% below the market average69.53% below the market average69.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
32.37% above the market average32.37% above the market average32.37% above the market average32.37% above the market average32.37% above the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Income Not Available
Growth
36.16% above the market average36.16% above the market average36.16% above the market average36.16% above the market average36.16% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

OBI Dividends

No dividends found

Trades for 10-Jun-2025

Time Volume / Share Price
15:48 4,621 @ 10.95p
15:47 1,500 @ 10.95p
15:39 10,356 @ 10.95p
14:23 22,831 @ 10.95p
13:45 18,349 @ 10.88p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page